Physician profile
Kelsey E Barton
NPI 1487289443
$2,090.15
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $450 · 2022: $512 · 2023: $821 · 2024: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,128.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $549.61 | 2021-2024 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $356.55 | 2022-2024 | |
| Novo Nordisk INC | $209.31 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $171.08 | 2021-2023 | Mounjaro, Emgality, Jardiance |
| Amgen INC. | $150.07 | 2021-2023 | Otezla, Repatha |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $81.91 | 2022-2023 | |
| Idorsia Pharmaceuticals US INC | $79.47 | 2022-2024 | Quviviq |
| Janssen Pharmaceuticals, INC | $71.36 | 2021 | |
| Pfizer INC. | $60.14 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.26 | 2023-2024 | Tradjenta, Jardiance, Synjardy |
| Mylan Specialty L.P. | $47.30 | 2023-2024 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $45.55 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $42.81 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.20 | 2022 | |
| Eisai INC. | $30.04 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $24.93 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $24.87 | 2021 | |
| Edwards Lifesciences Corporation | $19.70 | 2022 | |
| Dexcom, INC. | $18.52 | 2024 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $13.37 | 2023 | Cologuard Collection Kit |
| Inogen, INC. | $12.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.